ER physician urges fellow lawmakers to consider funding medical marijuana research in Utah

adminEconomic, Medical Cannabis, News, Reform0 Comments

Laura Seitz, Deseret News
FILE — Senator Brian E. Shiozawa speaks at a Health and Human Services Interim Committee meeting at the Capitol in Salt Lake City on Wednesday, June 15, 2016.


SALT LAKE CITY — The only “medical marijuana” bill passed by Utah lawmakers in 2016 was a resolution urging the federal government to reclassify cannabis as a Schedule II drug, a change that would open the door to medical research.

Had Congress authorized the Drug Enforcement Administration to make that change, universities and pharmaceutical companies “would have already asked and answered the questions we’re trying to do now,” said Sen. Brian Shiozawa, R-Cottonwood Heights, addressing his legislative colleagues Wednesday during a meeting of the Utah Legislature’s Health and Human Services Committee.

One of those questions is whether Utah should launch into cannabis-based medicine research on its own under state-level legislation.

Read Full Article Here


Leave a Reply

Your email address will not be published. Required fields are marked *